MTA1 and metastatic malignant neoplasm in the lymph nodes: A high level of MTA1 protein is linked to enhanced lymph node metastasis and increased risk of CC recurrence, thus potentiating its clinical significance in future gene‐targeted therapies for CC patients (Liu et al., 2013).